The 8 references in paper V. ZAFIRAKI K., E. KOSMACHEVA D., В. ЗАФИРАКИ К., Е. КОСМАЧЕВА Д. (2017) “ПЕРИОПЕРАЦИОННЫЕ ОСЛОЖНЕНИЯ И ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ЧРЕСКОЖНЫХ КОРОНАРНЫХ ВМЕШАТЕЛЬСТВ ПРИ СТАБИЛЬНОЙ СТЕНОКАРДИИ У БОЛЬНЫХ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ // PERIOPERATIVE COMPLICATIONS AND REMOTE RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE ANGINA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE” / spz:neicon:ksma:y:2017:i:6:p:54-58

1
Windecker S., Kolh P., Windecker S., Alfonso F., Collet J.P., Cremer J., Falk V., Filippatos G., Hamm C., Head S.J., Jüni P., Kappetein A.P., Kastrati A., Knuuti J., Landmesser U., Laufer G., Neumann F.J., Richter D.J., Schauerte P., Sousa Uva M., Stefanini G.G., Taggart D.P., Torracca L., Valgimigli M., Wijns W., Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2014; 46(4): 517-92. doi: 10.1093/ejcts/ezu366.
(check this in PDF content)
2
Алекян Б.Г., Бузиашвили Ю.И., Голухова Е.З., Никитина Т.Г., Стаферов А.В., Закарян Н.В., Зимин В.Н., Фозилов Х.Г. Большие кардиальные осложнения при чрескожных коронарных вмешательствах – предикторы, причины развития, методы профилактики и алгоритмы лечебных мероприятий. Креативная кардиология. 2011; 1: 28-40. [Alekyan B.G., Buziashvili YU.I., Goluhova E.Z., Nikitina T.G., Staferov A.V., Zakaryan N.V., Zimin V.N., Fozilov H.G. Bol'shie kardial'nye oslozhneniya pri chreskozhnyh koronarnyh vmeshatel'stvah – prediktory, prichiny razvitiya, metody profilaktiki i algoritmy lechebnyh meropriyatij. Kreativnaya kardiologiya. 2011; 1: 28-40. (In Russ.)].
(check this in PDF content)
3
Enriquez J.R., Parikh S.V., Selzer F., Jacobs A.K., Marroquin O., Mulukutla S., Srinivas V., Holper E.M. Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung and Blood Institute dynamic registry. Chest. 2011; 140(3): 604-10. doi: 10.1378/chest.10-2644.
(check this in PDF content)
4
Dursunoglu N., Dursunoglu D., Yıldız A.İ., Uludag B., Alaçam Z.N., Sarıçopur A. A. Severity of coronary atherosclerosis in patients with COPD. Clin. Respir. J. 2017; 11(6): 751-756. doi: 10.1111/crj.12412.
(check this in PDF content)
5
Liang B.M., Xu Z.B., Yi Q., Ou X.M., Feng Y.L. Association of chronic obstructive pulmonary disease with coronary artery disease. Chin. Med. J. (Engl). 2013; 126(17): 3205-3208.
(check this in PDF content)
6
Topsakal R., Kalay N., Ozdogru I., Cetinkaya Y., Oymak S., Kaya M.G., Dogan A., Inanc M.T., Ergin A. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels. 2009; 24(3): 164-8. doi: 10.1007/s00380-008-1103-4.
(check this in PDF content)
7
Nicholls S.J., Tuzcu E.M., Schoenhagen P., Sipahi I., Crowe T., Kapadia S., Nissen S.E. Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study). Am. J. Cardiol. 2005; 96(12): 1636-9.
(check this in PDF content)
8
Zhang X.L., Chi Y.H., Wang le F., Wang H.S., Lin X.M. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention. Respirology. 2014; 19(5): 723-9. doi: 10.1111/resp.12295 Поступила / Received 02.10.2017
(check this in PDF content)